The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions, current medications have several limitations, ...

Depression continues to grapple a large proportion of the population. Given the side effects associated with the long-term ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions ...

Purpose. Published reports on placebo-controlled clinical trials and other studies investigating the use of pure opioid antagonists for the prevention and treatment of opioid-induced pruritus (OIP ...

Although, preclinical data suggest that the behavioral expression of opioid use is similar between male and female rodents, we do not have conclusive results on sex differences on craving and relapse ...

In addition, some of the excipients used to prepare oral modified-release opioid products, particularly talc, may lead to serious complications if these products are parenterally abused.

Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

TALLAHASSEE, fla. — A new state-wide report released by Florida Attorney General Ashley Moody Thursday reveals a promising downward trend in opioid-related deaths. According to the latest ...

Andy Beshear, a Democrat — aggressively pursued legal action against companies that make or distribute opioid-based medication. In the Kroger settlement, about $18 million will cover lawyers ...

Key rules on Medicare Advantage, telehealth and the No Surprises Act likely will be left for the Trump administration to ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.